Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Delayed-Release, Extended-Release Methylphenidate (Jornay PM) for Adolescents and Young Adults With Attention-Deficit/Hyperactivity Disorder and Cannabis Use Disorder | Chemically-Induced Disorders, attention deficit hyperactivity disorder, inattentive type, cannabis dependence, neurodevelopmental disorder, oppositional defiant disorder, psychiatric disorder, substance-related disorder | Not yet recruiting | Phase 4 | 2026-09-28 | NCT07838311 |